1821214-50-9
1821214-50-9
Chemical Structure
TT3
- CAS No.: 1821214-50-9
- Formula:C90H174N6O3
- Molecular Weight:1388.38
IUPAC Name: 3-chloro-4-(5-(methyl(o-tolyl)carbamoyl)furan-2-yl)phenyl sulfamate
InChIKey: KIOSQLHXJYTPDN-UHFFFAOYSA-N
SMILES: O=C(C1=CC(C(NCCCN(CCCCCCCCCCCC)CCCCCCCCCCCC)=O)=CC(C(NCCCN(CCCCCCCCCCCC)CCCCCCCCCCCC)=O)=C1)NCCCN(CCCCCCCCCCCC)CCCCCCCCCCCC
Biological Activity: TT3 is an ionizable lipid-like material and a lipid nanoparticle (LLNs)-based mRNA delivery vector. TT3 exhibits liver and spleen specificity and excellent delivery efficiency[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
TT3 | 98.0% | TT3 is an ionizable lipid-like material and a lipid nanoparticle (LLNs)-based mRNA delivery vector. TT3 exhibits liver and spleen specificity and excellent delivery efficiency. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Li B, Luo X, Deng B, et al. An Orthogonal Array Optimization of Lipid-like Nanoparticles for mRNA Delivery in Vivo. Nano Lett. 2015;15(12):8099-8107. [Content Brief]
- [2]. Jiang C, Mei M, Li B, et al. A non-viral CRISPR/Cas9 delivery system for therapeutically targeting HBV DNA and pcsk9 in vivo. Cell Res. 2017;27(3):440-443. [Content Brief]
